Francisco D. Salva - May 25, 2023 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Director
Signature
By: /s/ Francisco D. Salva
Stock symbol
VINC
Transactions as of
May 25, 2023
Transactions value $
$0
Form type
4
Date filed
5/30/2023, 04:05 PM
Previous filing
May 31, 2022
Next filing
Jun 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VINC Stock Option (right to buy) Award $0 +15K $0.00 15K May 25, 2023 Common Stock 15K $1.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of May 25, 2024, the next annual meeting of stockholders, or the consummation of a change of control, subject to the director's continued service.